다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Selecta Biosciences Inc (SELB)
Selecta Biosciences Inc (SELB) 뉴스

SELB

Selecta Biosciences (SELB)

Selecta Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SELB

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/08	20:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SELB	Selecta Biosciences Inc
2024/05/08	20:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/26	22:09	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/26	20:57	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/22	19:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/20	05:49	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/11	10:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/11	10:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/11	10:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/11	10:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/11	10:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/11	05:29	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/11	05:25	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/11	05:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/09	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SELB	Selecta Biosciences Inc
2024/04/02	05:32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SELB	Selecta Biosciences Inc
2024/03/29	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SELB	Selecta Biosciences Inc
2024/03/14	20:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SELB	Selecta Biosciences Inc
2024/03/07	21:08	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:SELB	Selecta Biosciences Inc
2024/03/07	21:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SELB	Selecta Biosciences Inc
2024/03/05	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SELB	Selecta Biosciences Inc
2024/02/15	07:27	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SELB	Selecta Biosciences Inc
2024/02/15	06:42	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SELB	Selecta Biosciences Inc
2024/02/15	02:38	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SELB	Selecta Biosciences Inc
2024/02/01	06:30	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SELB	Selecta Biosciences Inc
2024/01/24	06:05	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:SELB	Selecta Biosciences Inc
2024/01/20	06:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SELB	Selecta Biosciences Inc
2024/01/13	06:16	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SELB	Selecta Biosciences Inc
2024/01/08	22:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SELB	Selecta Biosciences Inc
2024/01/08	21:10	GlobeNewswire Inc.	Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity	NASDAQ:SELB	Selecta Biosciences Inc

검색 관련기사 보기:NASDAQ:SELB

1 2 3 4 5 6 7 8 9 10 다음 >>

Vontobel Financial Produ...

Citigroup Global Markets...

Vontobel Financial Produ...

Richard Bernstein Adviso...

FinTech Acquisition Corp...

John Bean Technologies

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관